The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

AKBULUT H., Öçal M., Sonugür F. G., Babahan C., Abdi Abgarmi S.

ASCO 2018, 1 - 04 June 2018, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Ankara University Affiliated: Yes